Jane Street’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$844K Buy
9,800
+7,000
+250% +$628K ﹤0.01% 6880
2025
Q4
$244K Sell
2,800
-3,300
-54% -$250K ﹤0.01% 9291
2025
Q3
$349K Buy
+6,100
New +$351K ﹤0.01% 8619
2025
Q1
Sell
-6,100
Closed -$505K 9847
2024
Q4
$505K Buy
+6,100
New +$481K ﹤0.01% 6766
2023
Q2
Sell
-13,500
Closed -$765K 9006
2023
Q1
$765K Buy
+13,500
New +$866K ﹤0.01% 5542
2022
Q2
Sell
-13,700
Closed -$1.01M 10083
2022
Q1
$1.01M Buy
13,700
+2,100
+18% +$146K ﹤0.01% 6113
2021
Q4
$838K Buy
11,600
+7,900
+214% +$573K ﹤0.01% 6262
2021
Q3
$283K Buy
+3,700
New +$297K ﹤0.01% 8308
2021
Q2
Sell
-4,500
Closed -$278K 9988
2021
Q1
$278K Sell
4,500
-2,000
-31% -$127K ﹤0.01% 7805
2020
Q4
$424K Buy
+6,500
New +$374K ﹤0.01% 5965
2020
Q3
Sell
-6,900
Closed -$329K 7418
2020
Q2
$329K Buy
+6,900
New +$333K ﹤0.01% 5699
2016
Q2
Sell
-11,400
Closed -$271K 4249
2016
Q1
$271K Buy
+11,400
New +$279K ﹤0.01% 3337

Other funds holding GMED

Jane Street's GMED Position: Q1 2026 in Review

Jane Street reduced its Globus Medical (GMED) stake by 1.2% in Q1 2026, selling an estimated $110K and leaving 99,111 shares worth $8.54M. The position accounts for ﹤0.01% of the portfolio, ranked #2737.

Jane Street first reported a position in GMED in Q2 2013 and has held it in 28 quarters since. The position peaked at $31.8M in Q2 2020. 603 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Jane Street held 99,111 shares of Globus Medical worth $8.54M as of Q1 2026.
  • Jane Street sold 1,229 Globus Medical shares in Q1 2026, an estimated $110K.
  • Globus Medical made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #2737 holding.
  • Jane Street first reported a position in Globus Medical in Q2 2013 and has held it in 28 quarters since.
  • Jane Street's Globus Medical position peaked at $31.8M in Q2 2020.
  • 603 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.